American pharmaceutical giant Johnson & Johnson (JNJ) is boosting its U.S. investments by 25% to more than $55 billion over ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

PHARMACEUTICAL company Indies Pharma Jamaica Limited has secured US$405,000 or just over $60 million in its first drawdown ...

Stock analysts at Zacks Research increased their Q1 2025 earnings per share estimates for shares of Jazz Pharmaceuticals in a ...

Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report)‘s stock had its “market perform” rating reiterated by equities ...

The document outlines various health-related news, including a measles outbreak in Texas and New Mexico, UNICEF's aid crisis ...

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...

Novartis Pharmaceuticals is removing hundreds of New Jersey employees from its company. The global drugmaker will lay off 427 ...

Innate Pharma continues its slow rollout of promising clinical candidates, with 2025 set for key milestones. Read more about ...

Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

Given the present uncertainty, we need to wait and watch on how the tariff situation evolves. However, it is likely that in ...

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...